Newport Beach, Calif., June 8, 2016 — Red Herring North America announced Portal Instruments as one of its Top 100 award winners in recognition for being one of the leading private companies in the region. “We are pleased that our transformative drug delivery approach has been selected as a Red Herring North America Top 100 winner. This recognition will ultimately help drive the adoption of our technology and benefit patient outcomes,” said Patrick Anquetil, Chief Executive Officer of Portal Instruments.
Since 1996, Red Herring Top 100 has been enlisting outstanding entrepreneurs and promising companies, and annually selects award winners from a pool of over 1,200 privately financed companies. Red Herring editors were among the first to recognize that such companies as Facebook, Twitter, Google, Yahoo, Skype, Salesforce.com, YouTube, Palo Alto Networks, and eBay would change the way we live and work.
“In 2016, selecting the top achievers was extremely difficult,” said Alex Vieux, CEO and publisher of Red Herring. “The variety, depth, disruption and traction we saw from the early stage companies to those with significant scale made it one of the toughest vintages to judge. The North America winners are representative of the amazing ecosystem that never ceases to astound, with new and experienced entrepreneurs continuing to push the barriers of innovation. As one of the winners, Portal Instruments should be proud of its accomplishment under such strong competition.”
Red Herring’s editorial staff evaluated companies on both quantitative and qualitative criteria, such as financial performance, technological innovation and intellectual property, DNA of the founders, business model, customer footprint, and market penetration. This assessment of potential is complemented by a review of the track record and standing of startups relative to their sector peers, allowing Red Herring to see past the “buzz” and make the list a valuable instrument of discovery and advocacy for the most promising new business models in North America.
About Portal Instruments, Inc.
Portal Instruments is a Series B funded medical device company focused on advanced drug delivery and backed by strategic and venture investors. We are developing and commercializing a highly innovative needle-free drug delivery platform technology to transform the administration of medicines and improve the patient experience for chronic diseases. Portal’s needle-free delivery technology is derived from research at MIT and enables the administration of high viscosity biologic drugs with significantly less discomfort and without the anxiety of handling needles. Real time tracking and reporting sets a new standard for interactivity between the patient and care teams, monitoring adherence and potentially improving patient outcomes.
For more information, visit: www.portalinstruments.com or @portalcambridge on Twitter.
Contact Information
Dr. Patrick Anquetil
Chief Executive Officer
Pages of the Portal Instruments website may contain links to third party websites that are not under the control of Portal Instruments. Portal Instruments is not responsible for the content of any such site and the inclusion of these links does not imply the endorsement of the content of the linked site by Portal Instruments.
Portal’s platform is in development and not available for sale or use.